Prazosin addition to fluvoxamine / Matthijs G.P. Feenstra en European Neuropsychopharmacology, Año 2016 - Vol. 26 - No.2 (Febrero)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2016 - Vol. 26 - No.2 (Febrero) . - pp. 310-319 Título : Prazosin addition to fluvoxamine : A preclinical study and open clinical trial in OCD Tipo de documento: texto impreso Autores: Matthijs G.P. Feenstra, Autor ; André A. Klompmakers, Autor ; Martijn Figee, Autor Fecha de publicación: 2021 Artículo en la página: pp. 310-319 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Dopamina, Serotonina, Corteza prefrontal, Aumento, Trastorno obsesivo compulsivo Resumen: The efficacy of selective serotonin reuptake inhibitors (SRIs) in psychiatric disorders may be “augmented” through the addition of atypical antipsychotic drugs. A synergistic increase in dopamine (DA) release in the prefrontal cortex has been suggested to underlie this augmentation effect, though the mechanism of action is not clear yet. Link: ./index.php?lvl=notice_display&id=26612 [artículo] Prazosin addition to fluvoxamine : A preclinical study and open clinical trial in OCD [texto impreso] / Matthijs G.P. Feenstra, Autor ; André A. Klompmakers, Autor ; Martijn Figee, Autor . - 2021 . - pp. 310-319. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No.2 (Febrero) . - pp. 310-319 Palabras clave: Dopamina, Serotonina, Corteza prefrontal, Aumento, Trastorno obsesivo compulsivo Resumen: The efficacy of selective serotonin reuptake inhibitors (SRIs) in psychiatric disorders may be “augmented” through the addition of atypical antipsychotic drugs. A synergistic increase in dopamine (DA) release in the prefrontal cortex has been suggested to underlie this augmentation effect, though the mechanism of action is not clear yet. Link: ./index.php?lvl=notice_display&id=26612

---

1 (1 - 1 / 1)